Eicosapentaenoic Acid and Docosahexaenoic Acid (EPA + DHA)
PKE LPS
Phase 3 mab completed
Quick answer
Eicosapentaenoic Acid and Docosahexaenoic Acid (EPA + DHA) for Cardiovascular Disease is a Phase 3 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Cardiovascular Disease
- Phase
- Phase 3
- Modality
- mab
- Status
- completed